Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus Obtained Via a Non-invasive Screening Protocol

NCT04664036 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT04664036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus Obtained Via a Non-invasive Screening Protocol
Lead sponsor
University Hospital, Antwerp
Phase
Observational
Overall status
Unknown status
Start date
September 17, 2018
Completion date
July 30, 2025
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, nafld, type 1 diabetes